Alto Neuroscience (ANRO) Interest Coverage Ratio (2023 - 2026)
Alto Neuroscience's (ANRO) quarterly Interest Coverage Ratio came in at 49.79 in Q1 2026, down 89.95% year-on-year from 495.64 in Q1 2025, and down 67.88% quarter-over-quarter from 29.66 in Q4 2025.
Alto Neuroscience (ANRO) Interest Coverage Ratio (2023 - 2026) Analysis & Trends
Alto Neuroscience has disclosed Interest Coverage Ratio across 4 years of filings, most recently posting 49.79 for Q1 2026.
- Interest Coverage Ratio for Q1 2026 came in at 49.79, down 89.95% year-over-year; the trailing twelve-month figure through Mar 2026 was 32.21 (up 25.02% YoY), and the FY2025 annual result was 26.88, up 46.13% from the prior year.
- Interest Coverage Ratio came in at 49.79 for Q1 2026 at Alto Neuroscience, down from 29.66 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 22.23 in Q1 2023 to a low of 54.11 in Q3 2024.
- The 4-year median for Interest Coverage Ratio is 29.66 (2025), against an average of 35.93.
- Across the five-year window, Interest Coverage Ratio sank 102.14% in 2024 and surged 57.49% in 2025, its largest moves.
- Alto Neuroscience's Interest Coverage Ratio stood at 33.05 in 2023, then slumped by 54.45% to 51.04 in 2024, then soared by 41.89% to 29.66 in 2025, then sank by 67.88% to 49.79 in 2026.
- The last three Interest Coverage Ratio figures came in at 49.79 (Q1 2026), 29.66 (Q4 2025), and 23.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -258.33 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 11.79 |
| 10 | Alto Neuroscience | 643.06 Mn | 379.30 Mn | - | -49.79 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -49.79 |
| Dec 31, 2025 | -29.66 |
| Sep 30, 2025 | -23.00 |
| Jun 30, 2025 | -28.92 |
| Mar 31, 2025 | -26.21 |
| Dec 31, 2024 | -51.04 |
| Sep 30, 2024 | -54.11 |
| Jun 30, 2024 | -52.86 |
| Mar 31, 2024 | -41.58 |
| Dec 31, 2023 | -33.05 |
| Sep 30, 2023 | -26.77 |
| Jun 30, 2023 | -27.91 |
| Mar 31, 2023 | -22.23 |